Fund Holdings — MPM BioImpact LLC

Total Portfolio Value:
$427.43M
Total Bought:
$64.14M
Total Sold:
$38.50M
Net Transaction:
+$25.65M
Notable People:
Ansbert K Gadicke
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Cullinan Therapeutics, Inc.(CGEM)7,648,2687,648,2680$69.22M$77.94M18.23%+$8.72M
Iovance Biotherapeutics, Inc.(IOVA)3,287,3973,289,470+2,073$14.96M$26.74M6.26%+$11.79M
Olema Pharmaceuticals, Inc.(OLMA)1,857,6811,857,136-545$22.94M$26.06M6.10%+$3.11M
Geron Corporation(GERN)10,712,48110,715,620+3,139$22.71M$22.61M5.29%-$100.5K
iTeos Therapeutics, Inc.1,745,9431,745,9430$19.12M$19.12M4.47%$0
ALX Oncology Holdings Inc.(ALXO)01,264,759+1,264,759$0$18.83M4.41%+$18.83M
MoonLake ImmunotherapeuticsCL A(MLTX)294,190294,576+386$16.77M$17.79M4.16%+$1.02M
Crinetics Pharmaceuticals Inc.479,053478,234-819$14.25M$17.02M3.98%+$2.77M
Karuna Therapeutics Inc53,21053,279+69$9.00M$16.86M3.95%+$7.87M
Insmed Incorporated(INSM)527,458528,150+692$13.32M$16.37M3.83%+$3.05M
Cymabay Therapeutics Inc610,770611,181+411$9.11M$14.44M3.38%+$5.33M
Repare Therapeutics, Inc.1,639,8491,639,8490$19.81M$11.97M2.80%-$7.84M
Intellia Therapeutics, Inc.(NTLA)544,639382,598-162,041$17.22M$11.67M2.73%-$5.56M
Amicus Therapeutics Inc.
COM
716,139715,883-256$8.71M$10.16M2.38%+$1.45M
REGENXBIO Inc.(RGNX)656,718549,078-107,640$10.81M$9.86M2.31%-$953.6K
Madrigal Pharmaceuticals, Inc.(MDGL)40,85940,910+51$5.97M$9.47M2.21%+$3.50M
Structure Therapeutics Inc.ADS230,761230,696-65$11.63M$9.40M2.20%-$2.23M
Avadel Pharmaceuticals PLCADR664,224664,986+762$6.84M$9.39M2.20%+$2.55M
Morphic Holding Inc200,000323,742+123,742$4.58M$9.35M2.19%+$4.77M
Werewolf Therapeutics, Inc.(HOWL)2,388,0112,388,0110$5.11M$9.22M2.16%+$4.11M
Relay Therapeutics, Inc.(RLAY)1,352,133832,017-520,116$11.37M$9.16M2.14%-$2.21M
Xeris Biopharma Holdings Inc3,987,9673,847,232-140,735$7.42M$9.04M2.12%+$1.62M
Verve Therapeutics, Inc857,940638,163-219,777$11.38M$8.90M2.08%-$2.48M
Revolution Medicines, Inc.(RVMD)273,408273,4080$7.57M$7.84M1.83%+$273.4K
Axsome Therapeutics, Inc.(AXSM)93,58693,387-199$6.54M$7.43M1.74%+$891.9K
Viking Therapeutics, Inc.(VKTX)325,000325,284+284$3.60M$6.05M1.42%+$2.46M
Adaptimmune Therapeutics plcADR(ADAPY)5,095,9125,095,9120$3.97M$4.04M0.95%+$66.2K
Harpoon Therapeutics, Inc.319,670319,6700$1.29M$3.63M0.85%+$2.35M
Disc Medicine, Inc.(IRON)050,000+50,000$0$2.89M0.68%+$2.89M
Viridian Therapeutics, Inc.(VRDN)255,323100,000-155,323$3.92M$2.18M0.51%-$1.74M
Inozyme Pharma Inc.326,921323,813-3,108$1.37M$1.38M0.32%+$6.4K
Phathom Pharmaceuticals, Inc.(PHAT)347,33270,000-277,332$3.60M$639.1K0.15%-$2.96M
Kalvista Pharmaceuticals IncCommon577,9580-577,958$5.57M$0—-$5.57M
Travere Therapeutics Inc.Common(TVTX)552,8460-552,846$4.94M$0—-$4.94M
Page 1 of 1
MPM BioImpact LLC — 13F Holdings — Q4 2023 | TickerTrail